28
Oct
2025

DMG Italia Srl.

Exhibitor at CPHI Frankfurt 2025 stand 3.1H67, Finished Dosage Formulations
About Us

D.M.G. ITALIA S.R.L. is a private, independent company, engaged in the development of innovative Medical Device Substances using its proprietary formulations and involved in R&D, Manufacturing and Marketing. The company's areas of therapeutic focus are: Gastroenterology, Ent, Paediatrics, Ophthalmology, Orthopedics and Stomatology.

We are looking for Distributors who are willing to promote our Products in all the Countries listed in the Sales Market section below.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IT
  • 2020
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Medical Devices
Nutraceuticals
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1H67, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • GASTROTUSS SYRUP & TABLETS - Anti-Reflux Line

    Product GASTROTUSS SYRUP & TABLETS - Anti-Reflux Line

    A quick action against the symptoms of GERD and EERD for all the family. A complete Anti-Reflux Line composed by: • GASTROTUSS - Anti-Reflux Syrup, Medical Device class IIa, Presentation: 200/500 ml Bottle or 20 Monodose Bags 20 ml each
    • GASTROTUSS - Anti-Reflux Chewable Tablets, Medical Device cla...
  • PANAVIRAL LINE - No room for viruses and bacteria

    Product PANAVIRAL LINE - No room for viruses and bacteria

    A daily, safe, non-pharmacological strategy to preventnasal infections, leaving no room for viruses and bacteria. Two different presentations: • PANAVIRAL SPRAY, Medical Device class I, Presentation: 20 ml Spray • PANAVIRAL DROPS, Medical Device class I, Presentation: 15 ml Drops
  • NARIVENT NASAL SPRAY - A new direction in the treatment of Inflammation - Antiedemigen Nasal Spray

    Product NARIVENT NASAL SPRAY - A new direction in the treatment of Inflammation - Antiedemigen Nasal Spray

    Osmotically acting medical device with antiedemigen and phlogolitic effects.
    Narivent Anti-Edema Nasal Spray is an osmoticallyacting medical device with anti-edema and phlogoliticeffect, indicated: • for the reduction of nasal obstruction in patients affectedby nasal turbinate hypertrophy and by spe...
  • OPHTHA HYAL Line - THE EYE, WINDOW TO THE SOUL, WINDOW TO THE WORLD

    Product OPHTHA HYAL Line - THE EYE, WINDOW TO THE SOUL, WINDOW TO THE WORLD

    SafloHyal - in case of OCULAR INFLAMMATION
    Key Ingredients: Enoxolone glucuronide 2.5 %, Hyaluronic Acid Sodium Salt 0.10%, PEG/PPG (EG56) 1.5%.

    OftaxHyal - in case of CORNEAL INJURIES
    Key Ingredients: Hyaluronic Acid, Glyceryl...
  • RINOPANTEINA LINE - A Line for the Lubrication of Nasal Mucosa

    Product RINOPANTEINA LINE - A Line for the Lubrication of Nasal Mucosa

    Medical Devices useful to lubricate and maintain the hydration of the nasal mucosa, help the re-epithelization process.
    Three presentations:
    • Nasal Spray with Vitamin A and Vitamin E - Medical Device class IIa • Nasal Drops - Medical Device class IIb • Nasal Ointment - Medical Device class IIb q...